INTRODUCTION
Arginase is the last enzyme functional in the urea cycle and catalyzes the conversion of arginine to urea and ornithine in the liver of ureotelic animals. Arginase from rat (Schimke, 1962; Hirsch-Kolb and Greenberg, 1968; Tarrab et al., 1974) , rabbit (Vielle-Breitburd and Orth, 1972) and human (Beruter et al., 1978; Brusdeilins et al., 1985) livers has been purified and was found to consist of three identical subunits (Penninckx et al., 1974) of about 35,000 daltons. Arginase isozyme(s) that differs from the liver enzyme in catalytic, molecular and immunological properties, is present in the kidney, small intestine and lactating mammary gland (Glass and Knox, 1973; Herzfeld and Raper, 1976; Skrzypek-Osiecka et aL, 1983; Spector et al., 1983) . A deficiency in human liver arginase results in argininemia, an inherited autosomal recessive disorder accompanied by hyperammonemia (Walser, 1983) . We isolated eDNA clones for rat and human (Haraguchi et al., 1987) liver arginase and determined the nucleotide sequences. Sparkes et al. (1986) also isolated human liver arginase eDNA and assigned the gene to chromosome band 6q23. During isolation of human arginase eDNA clones, we found several distinct groups of cDNAs which differed in restriction maps, therefore, we determined the entire sequences of eight independent clones. We now report nucleotide and amino acid sequence heterogeneity of human liver arginase eDNA and protein. Two restriction fragment length polymorphisms (RFLPs) of the gene locus are also reported.
MATERIALS AND METHODS
Isolation of human liver arginase eDNA clones. An oligo(dT)-primed human liver eDNA library in 2gtll and a random primer library in 2gtll were screened by plaque hybridization, as described (Haraguchi et al., 1987) . The eDNA libraries were kindly provided by G.A. Ricca (Meloy Laboratories, Springfield, Va., USA) and by Y. Ebina (Kumamoto University) and J. Ou (University of California, San Francisco, Calif., USA), respectively. Each library was prepared from the hepatic mRNA of one individual. Plaques of positive clones were purified, and EcoRIexcised eDNA inserts were subcloned into a plasmid vector pUC9 and characterized by restriction endonuclease mapping.
Nucleotide sequence determination. The pUC9 subclones were directly subjected to nucleotide sequencing by the dideoxynucleotide chain termination method (Sanger et ai., 1977) , using an alkali-denatured plasmid as a template (Hattori and Sakaki, 1986 ) and a synthetic oligonucleotide as a primer. Oligonucleotide primers were synthesized using a DNA synthesizer (Model 381A, Applied Biosystems, Foster City, Calif., USA).
Southern blot analysis. DNA was prepared from peripheral blood lymphocytes, by the established procedure (Bell et aI., 1981) . DNA (10 pg) was digested for 18 hr with restriction endonucleases PvuII, Taql, or HinclI (Takara Shuzo, Kyoto, or Toyobo Biochemicals, Tokyo; 50 units each) under the conditions recommended by the supplier. The digests were separated by agarose gel electrophoresis (0.7-0.8~ agarose, 14-16 hr at 1.9 V/cm), and transferred to nitrocellulose filters. Hybridization was carried out according to Maniatis et al. (1982) using nick-translated, 3zP-labeled eDNA (full-length, 1 x l0 s dpm/#g DNA) as a probe. The filters were then washed and exposed for several days at -70~ to a Fuji RX film with an intensifying screen. (Fig. 1) . Among these plasmids, the plasmid phARG 6 was identified as an arginase cDNA clone, because the bacterial clone carrying this plasmid had an arginase activity whereas the bacteria carry- ing no plasmid or the cloning vector pUC9 had no detectable activity (Haraguchi et al., 1987) . The entire nucleotide sequence of phARG 6 (which lacked the NH2-terminal eight amino acid residues) and the 5' region sequence of phARG 109 which extended further into the 5' direction, were determined (Haraguchi et al., 1987) . Sequencing of the remaining portion of phARG 109 revealed two base substitutions between these two cDNA clones (Fig. 1 ). C at nucleotide position 256 and T at position 617 in phARG 6 were replaced by G and A, respectively. Both base substitutions were accompanied by amino acid substitutions, Gln to Glu and Leu to Gln, respectively (Fig. 1) . Profound variations were seen in restriction maps between the eight clones. We then examined almost all of the nucleotide sequences of these clones and the results are summarized in Fig. 1 . phARG 2, phARG 3 and phARG 103 were composed of human liver arginase cDNAs and distinct sequences quite different from that of arginase cDNA. Among these sequences, one (in phARG 103) was found to be the 5' portion of intron 3 which was not spliced out from the mRNA precursor for human liver arginase (unpublished results), whereas the other The positions of the amino acid substitutions are shown along with the sequence comparison of human liver, rat liver and yeast arginases (Fig. 3) . The Met-Lys variation at amino acid residue 1 resulted in a loss of the initiator methionine. With respect to Gln-Glu variation at residue 86, Glu is the major form and is conserved in the sequence in the rat. For Ser-Phe variation at residue 109, Ser is the major form and is conserved among the three species. For the Leu-Gln variation at residue Hydropathy profile of human liver arginase and positions of amino acid substitutions. Hydropathy profile was analyzed according to Kyte and Doolittle (1982) . The amino acid substitutions are shown above the hydropathy profile.
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RESULTS
Sequence heterogeneity
206, Leu is the major form and is conserved in the sequence in the rat. For the Val-Ala variation at position 233, Val is the major form and is conserved among the three species. Hydropathy profiles of human liver arginase and positions of the amino acid substitutions are shown in Fig. 4 . The arginase has a number of relatively short hydrophobic and hydrophilic regions. The residue 1 of Met-Lys variation is located at a hydrophilic region (the hydropathy profile of this region is not shown). The residues of the three variations (residues 86, 109 and 233) are situated at regions of hydropathy value of near zero, whereas that of the other variation (residue 206) is situated at a hydrophilic region.
RFLPs of the arginase gene locus
DNAs from healthy Japanese individuals were digested with restriction endonucleases PvuII, TaqI or HinclI, and the digests were subjected to Southern blot analysis using human liver arginase cDNA as a probe. No RFLP was found with TaqI (data not shown). On the other hand, an RFLP was found with PvulI (Fig.  5A) . The 2.8 kilobase (kb) fragment was present in only 2 of the 14 individuals. This 2.8 kb fragment appeared to be allelic to 1.5 kb and 1.3 kb fragments. Thus, individuals 1 and 2 were heterozygous for the 2.8 kb allele and the 1.5 kb and 1.3 kb allele, whereas the other individuals were homozygous for the 1.5 plus 1.3 kb allele. Frequency of the 2.8 kb allele was 2/28 or about 7~. Another RFLP was found with HincII. The 1.2 kb fragment which is apparently allelic to 1.5 kb fragment, was present only in individuals 4 and 11 but not in others. Thus, the former two individuals were heterozygous for the 1.5 kb and 1.2 kb allele whereas the other individuals were homozygous for the 1.5 kb allele. Frequency of the 1.2 kb allele In addition to these arginase cDNA-unrelated sequences, five base alterations were found in the protein-coding region among the eight eDNA clones and all these base alterations were accompanied by amino acid alterations. Among the five alterations, the T-A alteration at nucleotide position 2 and C-T alteration at position 326 may be due to cloning artifacts because they were situated near 5' termini of the clones and because the substitution at position 2 resulted in a loss of the initiation methionine codon. If these two variations are omitted, one eDNA library (oligo(dT)-primed, Library A in Fig. 1 ) contained three distinct cDNA species and the other library (random primer-primed, Library B in Fig. 1 ) contained two distinct cDNAs. Each library was constructed from hepatic mRNA of one individual. Multiple cDNA species may arise from the two alleles, multiple gene loci, RNA polymerase errors or cloning artifacts. Genomic Southern blotting and genomic cloning revealed a single copy gene for human liver arginase (unpublished results). It is very unlikely that all these variations are due to RNA polymerase errors or cloning artifacts, although one of the three distinct cDNAs in Library A may be due to one of these errors. All these results strongly suggest that the two distinct cDNAs in each library are allelic and that the human liver arginase is highly polymorphic in amino acid sequence. These sequence polymorphisms can be checked using sequence-specific oligonucleotide probes.
Two RFLPs of the human liver arginase gene were found with the enzyme PvuII and HincII. The frequencies of the minor components of these two RFLPs are 7 and 9~, respectively. These two RFLPs are closely linked. Kidd et al. (1986) noted a similar PvuII RFLP of the arginase gene in Caucasians. Frequency of the minor 2.8 kb allele was 14~ (91 individuals). Thus, no marked difference was observed in allele frequency between Japanese and Caucasian populations. On the other hand, in contrast to our findings, they detected no RFLP with HincII, when tested on 13 individuals. The reason of this discrepancy has yet to be determined. In any case, these RFLPs can be used in the DNA diagnosis of argininemia, only in limited cases. Other RFLPs are now being searched for using other restriction endonucleases and, as probes, genomic fragments. If the sequence polymorphism mentioned above is valid, then the DNA diagnosis using sequence-specific oligonucleotides will be feasible.
